586 filings
PRE 14A
DARE
Dare Bioscience Inc
Preliminary proxy
16 Apr 24
4:20pm
S-3
DARE
Dare Bioscience Inc
Shelf registration
29 Mar 24
4:06pm
S-3
DARE
Dare Bioscience Inc
Shelf registration
29 Mar 24
4:06pm
424B5
DARE
Dare Bioscience Inc
28 Mar 24
Prospectus supplement for primary offering
4:06pm
10-K
2023 FY
DARE
Dare Bioscience Inc
Annual report
28 Mar 24
4:01pm
8-K
mr31r4s1f0
28 Mar 24
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
8:05am
4
x25e3t98
14 Mar 24
Dare Bioscience / John A Fair ownership change
4:39pm
4
k0hefwzx7
14 Mar 24
Dare Bioscience / SABRINA MARTUCCI JOHNSON ownership change
4:34pm
4
tje0 6lmru2ga5h7b
14 Mar 24
Dare Bioscience / MarDee Haring-Layton ownership change
4:28pm
3
t19i0y0y
29 Jan 24
Dare Bioscience / MarDee Haring-Layton ownership change
4:18pm
8-K
w7q0ze2ldfb 7gi
26 Jan 24
Daré Bioscience Announces Executive Team and Board of Directors Changes
5:15pm
8-K
f4yukdb9tlt0babufz1
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
poiutlj9olaayfpp8k
8 Jan 24
Regulation FD Disclosure
8:00am
D
3wmeolgk vg
26 Dec 23
$4.16 mm in options / securities to be acquired, sold $1.73 mm, 1 investor
4:05pm
8-K
rncuf8uo5ew5urf
26 Dec 23
Daré Bioscience Secures $12 million in Royalty-backed Investment Structure $5 million at closing and up to $7 million of additional committed funding
8:05am
8-K
k971ijel
20 Dec 23
Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study
8:05am
8-K
gw02gy
9 Nov 23
Changes in Registrant's Certifying Accountant
5:15pm
8-K
kmd8ms
9 Nov 23
Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update
8:05am
8-K
4nmc0kimxsjh
1 Nov 23
Regulation FD Disclosure
8:05am